Materials·Commodity Chemicals·$3.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.65 | N/A | -12.16% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.65 | N/A | -12.16% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about market conditions impacting performance. They highlighted a commitment to managing costs effectively.
Management noted challenges in the current market environment.
They emphasized a focus on cost control and efficiency.
There were no specific plans shared for future growth initiatives.
Hawkins Inc's earnings report showed a miss on EPS, which contributed to a 2.95% decline in stock price. The lack of revenue figures and forward guidance may raise concerns among investors about the company's future performance. Management's cautious tone suggests they are facing challenges in the market, which could impact growth moving forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERTEX PHARMACEUTICA
Oct 26, 2009